Senior insider sale
Chief Financial Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$8.26M
58.63K shares
What this filing means
ALI ASIF plans to sell 58.63K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $8.26M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/30/2026ACC: 0001950047-26-009883
Officer· Chief Financial Officer
Since Apr 2022
58.63K
Shares to sell
$8.26M
Approx. market value
58.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/30/2026
58.63KTotal acquired58.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/30/2026 | Exercise of Stock Options Cash | 58.63K | — |
| Total | 58.63K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
58.63K
Market value
$8.26M
9/30/2026
Total
Units
58.63K
Value
$8.26M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/30/2026 | 58.63K | $8.26M | NASDAQ | Planned |
| Total | 58.63K | $8.26M | ||